ΠΠ°Π»Π΅Π΅Π‘Π»Π΅Π΄ΡΡΡΠ΅Π΅ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ
ΠΠ Π² ΡΠΊΡΠΈΠ½ΠΈΠ½Π³Π΅ Π½Π° Π°ΡΡΠΈΠ·ΠΌ
ΠΡΡΠ°ΡΠ»ΠΈ
Π Π£ΠΠΠΠΠΠ‘Π’ΠΠ ΠΠ ΠΡΡΠ°ΡΠ»ΡΠΌ
WHO recommends computer-aided detection (CAD) software as one option for interpreting chest X-rays in tuberculosis screening for defined populations and indications; it flags images for follow-up but does not confirm tuberculosis.
ΠΡΠΎΡΠ»ΡΡΠ°ΠΉΡΠ΅ ΡΡΠΎ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎΠΠ·Π²ΡΡΠ΅Π½ΠΎ ΠΠ Β· ~3 min
WHOβs 2025 evaluation identified products meeting performance standards for screening people aged 15 and older, without extending that result to younger children, and positive screens need diagnostic testing, and programs should report the population and workflow used and review local referral responsibilities.
Tuberculosis screening aims to identify people who may need diagnostic evaluation, including people without symptoms in higher-risk settings. Chest X-rays can support screening, and computer-aided detection software can score images for TB-related abnormalities. The World Health Organization has recommended CAD for TB screening and issued a 2025 policy statement reporting an independent evaluation of available products. That statement identifies software meeting WHO performance standards for screening people aged 15 and older; it does not extend that recommendation to children younger than 15. A screening score is not a confirmed TB diagnosis. A positive result should lead to further evaluation and diagnostic tests under the local program. An unreadable or missing image also needs a defined follow-up, not a default assumption of no disease. False positives can create unnecessary tests and anxiety; false negatives can delay treatment and allow ongoing transmission. CAD performance depends on image equipment, population, disease prevalence, and the threshold chosen by the program. Programs should use products and protocols consistent with current WHO guidance, validate local workflows, and make referral and confirmatory testing available. Explain that AI is used to help interpret the X-ray and state what happens after each result. Monitor image quality, thresholds, diagnostic yield, false alarms, and follow-up completion. Do not use CAD as a standalone diagnosis or apply adult recommendations to children without current evidence and guidance.
A screening program uses a WHO-evaluated CAD tool on chest X-rays for the population specified in current guidance.
A person with a positive CAD screen receives confirmatory testing rather than being told the AI has diagnosed TB.
A clinic reviews unreadable images and follows the programβs referral protocol rather than treating them as negative.
A public-health team monitors referral completion, false positives, and performance in the communities being screened.
CAD screening may expand as devices and software improve, but country-level implementation depends on capacity to confirm results and provide treatment. WHO may update evaluated products and recommendations, so programs should check current guidance. Include affected communities in design, explain how images and scores are used, and preserve human review and referral pathways. Screening performance should be assessed across settings, not assumed from a benchmark alone. Recheck referral capacity as programs grow and community needs change. Maintain diagnostic capacity for positive screens.
ΠΠ΅ΡΠΏΠ»Π°ΡΠ½Π°Ρ ΡΠ°ΡΡΡΠ»ΠΊΠ°
Π’ΡΠΈ ΠΏΡΠΎΠ²Π΅ΡΠ΅Π½Π½ΡΡ AI-ΠΈΡΡΠΎΡΠΈΠΈ ΠΊΠ°ΠΆΠ΄ΠΎΠ΅ ΡΡΡΠΎ Π±ΡΠ΄Π½Π΅Π³ΠΎ Π΄Π½Ρ, Π½Π°ΠΏΠΈΡΠ°Π½Π½ΡΠ΅ ΠΏΡΠΎΡΡΡΠΌ Π°Π½Π³Π»ΠΈΠΉΡΠΊΠΈΠΌ. ΠΠ΅ΡΠΏΠ»Π°ΡΠ½ΠΎ Π½Π°Π²ΡΠ΅Π³Π΄Π°, Π±Π΅Π· ΡΠ΅ΠΊΠ»Π°ΠΌΡ.
ΠΠ΄Π½ΠΎ ΡΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΠΎΠ΅ ΠΏΠΈΡΡΠΌΠΎ ΠΊΠ°ΠΆΠ΄ΡΠΉ Π±ΡΠ΄Π½ΠΈΠΉ Π΄Π΅Π½Ρ. ΠΡΠΏΠΈΡΠ°ΡΡΡΡ Π² ΠΎΠ΄ΠΈΠ½ ΠΊΠ»ΠΈΠΊ. ΠΡ Π½ΠΈΠΊΠΎΠ³Π΄Π° Π½Π΅ ΠΏΡΠΎΠ΄Π°Π΅ΠΌ ΠΈ Π½Π΅ ΠΏΠ΅ΡΠ΅Π΄Π°Π΅ΠΌ Π²Π°Ρ Π°Π΄ΡΠ΅Ρ.
ΠΡΠΎΠ²Π΅ΡΡΡΠ΅ ΡΠ΅Π±Ρ
ΠΠ³Π½ΠΎΠ²Π΅Π½Π½Π°Ρ ΠΎΠ±ΡΠ°ΡΠ½Π°Ρ ΡΠ²ΡΠ·Ρ ΠΏΠΎ ΠΊΠ°ΠΆΠ΄ΠΎΠΌΡ ΠΎΡΠ²Π΅ΡΡ ΠΈ ΠΎΠ±ΡΠΈΠΉ ΡΠ΅ΡΡΠΈΡΠΈΠΊΠ°Ρ Ρ ΠΏΡΠΎΠ²Π΅ΡΡΠ΅ΠΌΡΠΌ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΎΡΠΎΠΌ ΠΏΠΎΡΠ»Π΅ ΠΏΡΠΎΡ ΠΎΠΆΠ΄Π΅Π½ΠΈΡ ΠΊΡΡΡΠ°.
ΠΠΎΠ΄Π΄Π΅ΡΠΆΠΈΡΠ΅ Π±Π΅ΡΠΏΠ»Π°ΡΠ½ΠΎΠ΅ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ Π² ΠΎΠ±Π»Π°ΡΡΠΈ ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠ΅Π»Π»Π΅ΠΊΡΠ°. AI Understanding β ΡΡΠΎ Π½Π΅ΠΊΠΎΠΌΠΌΠ΅ΡΡΠ΅ΡΠΊΠ°Ρ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡ 501(c)(3). ΠΠΈΠΊΠ°ΠΊΠΎΠΉ ΡΠ΅ΠΊΠ»Π°ΠΌΡ ΠΈ ΠΏΠ»Π°ΡΠ½ΠΎΠ³ΠΎ Π΄ΠΎΡΡΡΠΏΠ°. Π‘Π΄Π΅Π»Π°ΡΡ ΠΏΠΎΠΆΠ΅ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅
WHO recommends computer-aided detection (CAD) software as one option for interpreting chest X-rays in tuberculosis screening for defined populations and indications; it flags images for follow-up but does not confirm tuberculosis. WHOβs 2025 evaluation identified products meeting performance standards for screening people aged 15 and older, without extending that result to younger children, and positive screens need diagnostic testing, and programs should report the population and workflow used and review local referral responsibilities.
WHO describes CAD as an option to support chest X-ray screening, not confirmation.
The 2025 statement notes the evaluated recommendation applies to age 15 and older.
CAD is a screening aid; positive results need diagnostic testing.
Program quality depends on the full screening-to-diagnosis pathway.
Threshold performance depends on the population and screening context.
ΠΡΠΎΠ΄ΠΎΠ»ΠΆΠ°ΠΉΡΠ΅ ΡΡΠΈΡΡΡΡ
ΠΡΡΠ³ΠΈΠ΅ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²Π°, Π²ΡΠ±ΡΠ°Π½Π½ΡΠ΅ ΠΏΠΎ ΡΡΠΎΠΉ ΡΠ΅ΠΌΠ΅
ΠΠ°Π»Π΅Π΅Π‘Π»Π΅Π΄ΡΡΡΠ΅Π΅ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ
ΠΠ Π² ΡΠΊΡΠΈΠ½ΠΈΠ½Π³Π΅ Π½Π° Π°ΡΡΠΈΠ·ΠΌ
ΠΡΡΠ°ΡΠ»ΠΈ